Player FM - Internet Radio Done Right
Checked 2d ago
تمت الإضافة منذ قبل three أعوام
المحتوى المقدم من BioTech Nation Team and Moira Gunn. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة BioTech Nation Team and Moira Gunn أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
Player FM - تطبيق بودكاست
انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
المدونة الصوتية تستحق الاستماع
برعاية
T
The Innovators & Investors Podcast


1 Inside Deloitte Ventures: Strategic Corporate VC Insights on Scaling Startups and Vertical AI Trends 34:07
34:07
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب34:07
In this insightful episode of The Innovators & Investors Podcast, host Kristian Marquez sits down with Jay Crone, Managing Director and Venture Capitalist at Deloitte Ventures, to explore the firm’s strategic approach to corporate venture capital. Jay shares Deloitte Ventures’ investment thesis, focusing on supporting innovative Canadian startups at Series A and B stages across key sectors like cybersecurity, climate tech, fintech, future of work, health tech, and AI. Listeners will gain an inside look at how Deloitte leverages its vast network of 1,500 partners and 15,000 employees to source deals and add value beyond capital by helping startups navigate Deloitte’s complex ecosystem and access enterprise clients. Jay also discusses his diverse career journey—from government and investment banking to entrepreneurship and corporate VC—and how those experiences shape his investment philosophy. The episode delves into Deloitte’s due diligence process, the importance of founder relationships, and the firm’s strategic role as a co-investor. Jay highlights emerging trends, particularly the promise of vertical AI tailored to industry-specific needs, and shares his bullish outlook on fintech innovations like stablecoins and cross-border payments. He offers candid advice for entrepreneurs on risk-taking and aligning business vision with funding goals. This episode is a must-listen for founders, investors, and anyone interested in the evolving landscape of corporate venture capital and innovation in Canada. Learn more about Jay's work at https://www.deloitte.com/ca/en/services/program/ventures.html Connect with Jay on LinkedIn at https://www.linkedin.com/in/jaycrone/ Think you'd be a great guest on the show? Apply at https://finstratmgmt.com/innovators-investors-podcast/ Want to learn more about Kristian Marquez's work? Check out his website at https://finstratmgmt.com…
BioTech Nation ... with Dr. Moira Gunn
وسم كل الحلقات كغير/(كـ)مشغلة
Manage series 3360496
المحتوى المقدم من BioTech Nation Team and Moira Gunn. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة BioTech Nation Team and Moira Gunn أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the work of others, BioTech Nation is the voice of human endeavor, driving science to new realities for everyone. These interviews are drawn directly from the public radio program, "Tech Nation", which also can be heard in numerous global radio and podcasting venues.
…
continue reading
128 حلقات
وسم كل الحلقات كغير/(كـ)مشغلة
Manage series 3360496
المحتوى المقدم من BioTech Nation Team and Moira Gunn. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة BioTech Nation Team and Moira Gunn أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the work of others, BioTech Nation is the voice of human endeavor, driving science to new realities for everyone. These interviews are drawn directly from the public radio program, "Tech Nation", which also can be heard in numerous global radio and podcasting venues.
…
continue reading
128 حلقات
כל הפרקים
×
1 Solving Genetic Diseases??? Dr. Neil Kumar, Founder & CEO, BridgeBio Pharma 23:18
23:18
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب23:18
This week on Biotech Nation, Dr. Neil Kumar, founder and CEO of BridgeBio Pharma. Dr. Kumar emphasizes that genetic diseases, particularly Mendelian diseases caused by single gene mutations, are solvable due to advancements in genetic measurement and understanding. He discusses BridgeBio Pharma's innovative corporate structure, which consists of multiple specialized companies under a centralized infrastructure to efficiently tackle various genetic diseases. This model allows for focused expertise on individual conditions while sharing common resources. Dr. Kumar highlights the company's commitment to using diverse therapeutic modalities, such as small molecules and gene therapies, to develop treatments that address the underlying causes of these diseases.…

1 No More Transfusions!!! Dr. John Scarlett, President and CEO of Geron Corporation 16:10
16:10
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب16:10
Dr. John Scarlett, President and CEO of Geron Corporation talks about their drug Imetelstat for myelodysplastic syndrome (MDS). MDS patients often require frequent blood transfusions, impacting their quality of life. Imetelstat, a telomerase inhibitor, aims to reduce transfusion dependence by targeting cancer cells in the bone marrow. Phase three trials showed promising results, with 40% of patients experiencing at least an 8-week transfusion-free interval.…

1 The Science of a Stronger Heart... Robert Blum, CEO, CytoKinetics 15:47
15:47
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب15:47
This week on BioTech Nation, Robert Blum, CEO of CytoKinetics, joins me to talk about the company’s decades-long mission to keep hearts beating stronger and longer. With one heart drug under FDA review and more in the pipeline, CytoKinetics is working to address the full spectrum of heart failure, from weak hearts to overactive ones, and even exploring muscle health beyond the heart to support healthy aging.…

1 When Wounds Won't Heal... Jason Matuszewski, CEO, BioStem Technologies 9:46
9:46
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب9:46
This week on BioTech Nation, BioSTEM Technologies CEO Jason Matuszewski explains how donated placental tissue is being used to treat chronic wounds that just won’t heal, from diabetic ulcers to pressure sores. With millions affected and traditional care often falling short, BioSTEM’s approach offers a new way to support healing and reduce scarring.…

1 Snake Bite Man meets Biotech Scientist creates Breakthrough Antivenom Vaccine … Dr. Jake Glanville, Founder, Chairman & CEO of Centivax 34:53
34:53
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب34:53
This week on BioTech Nation, Biotech Entrepreneur, Dr. Jake Glanville, Founder, Chair and CEO of Centivax, gives us the insider’s view of this Biotech Breakthrough – from the first telephone call through each significant step, all leading to the first breakthrough generalized antivenom vaccine in 125 years.…

1 What’s Next in Health? Highlights from NextMed 2025... Dr. Daniel Kraft, Tech Nation Health Chief Correspondent 11:29
11:29
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب11:29
This week on BioTech Nation, Dr. Daniel Kraft, Tech Nation Health Chief Correspondent, returns with highlights from the 2025 NextMed Health conference. From AI-powered health agents to voice-based disease detection, hear what’s emerging at the intersection of medicine, technology, and global health equity.…

1 How Can a Treatment Become a Vaccine??? Dr. Peter DeMuth, Chief Scientific Officer at Elicio Therapeutics 23:33
23:33
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب23:33
Dr. Peter DeMuth, Chief Scientific Officer of Elicio Therapeutics, discusses the revolutionary approach of detecting cancer at its earliest stages through circulating tumor DNA (ctDNA) tests. Highlighting their innovative treatment method, which aims to train the body's immune cells to recognize and destroy cancer cells, the episode explores the potential transition from treatment to vaccine, offering hope for more effective and durable solutions.…

1 PART II: A Regenerative Leap for Epilepsy… Dr. Cory Nicholas, Co-Founder and CEO, Neurona Therapeuitcs 27:03
27:03
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب27:03
This week on BioTech Nation, Dr. Cory Nicholas, CEO of Neurona Therapeutics, returns for part two. With early results now in from Neurona’s first clinical trial, patients with severe epilepsy are seeing dramatic improvements, including seizure reductions of over 90 percent, and even full remission in some cases. This one-time treatment delivers new brain cells that help calm seizure activity without the side effects of traditional medications or the risks of surgery.…

1 PART 1: A Regenerative Leap for Epilepsy…Dr. Cory Nicholas, Co-Founder and CEO, Neurona Therapeutics 24:27
24:27
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب24:27
This week on BioTech Nation, Dr. Cory Nicholas, Co-Founder and CEO of Neurona Therapeutics, discusses their groundbreaking success in treating drug-resistant epilepsy. With a single, targeted delivery of lab-grown brain cells, Neurona is offering not just symptom control but the possibility of long-term seizure relief. This is Part 1 of a two-part series exploring the future of regenerative medicine in neurology.…

1 Fighting Cancer, Easing Pain... Dr. Lorin Johnson, CSO, Glycyx Therapeutics 17:23
17:23
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب17:23
This week on BioTech Nation, we explore a new approach to cancer treatment that could help patients manage pain without compromising their care. Dr. Lorin Johnson, CSO of Glycyx Therapeutics explains how a new once-daily pill could help patients manage pain without blocking their treatment.

1 Freezing Out Chronic Pain…Sameer Sabir CEO, Brixton Biosciences 14:21
14:21
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب14:21
This week on BioTech Nation, Sameer Sabir, CEO of Brixton Biosciences, shares how their breakthrough injectable cold therapy, Neural Ice, could offer lasting relief for osteoarthritis pain. With a drug-free, nerve-targeting approach currently in clinical trials, this innovation may change how we treat joint pain without pills or repeated steroid injections.…

1 Beyond the One-Size-Fits-All Cure... Jeff Liter, Founder & CEO, Luminary Therapeutics 11:21
11:21
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب11:21
This week on BioTech Nation, Luminary Therapeutics CEO Jeff Liter shares how his team is working to make advanced cell therapy easier to access and more affordable. Instead of using each patient’s own cells, they use healthy donor cells that are ready to go. This approach could help more people get treated for cancer and autoimmune diseases like lupus, with just a single dose.…

1 Beyond Pills and Shots... Sean Ainsworth, CEO, Immusoft 12:44
12:44
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب12:44
This week on BioTech Nation, Sean Ainsworth, CEO of ImmuSoft, explains how modifying the body’s own B cells to produce therapeutic proteins could revolutionize drug delivery. From improving treatment for rare diseases like Hurler syndrome to potentially replacing injections for autoimmune and metabolic conditions, this new approach opens the door to long-term, patient-specific solutions.…

1 Breaking Barriers in Brain Cancer... Dr. Thomas Chen, Founder and CEO, NeOnc Technologies 24:39
24:39
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب24:39
This week on BioTech Nation, Dr. Thomas Chen, Director of Neuro-Oncology at USC and Founder of NeOnc Technologies, shares treating glioblastoma by delivering a drug directly to the brain through nasal inhalation changes the drug delivery game, bypassing the blood-brain barrier. This technique is achieving results in clinical trials.…

1 The Future of Synthetic Biology... Dr. John Cumbers, Founder & CEO, SynBioBeta 18:53
18:53
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب18:53
This week on BioTech Nation, I speak with Dr. John Cumbers, founder and CEO of SynBioBeta, the annual synthetic biology conference. We discuss how biology, AI, and technology are transforming industries, covering tracks on human health, planetary health, and hyperscale biology. SynBioBeta 2025 will take place in San Jose, CA, from May 5 to 8.…
B
BioTech Nation ... with Dr. Moira Gunn

1 Reimagining Bone Marrow Transplants... Kevin Caldwell, Co-Founder & CEO, Ossium Health 13:29
13:29
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب13:29
This week on BioTech Nation, Ossium Health co-founder and CEO Kevin Caldwell shares how their breakthrough approach is changing bone marrow transplants. By cryobanking marrow from organ donors, Ossium is reducing wait times, improving access, and preparing for future emergencies. With support from BARDA and promising clinical trial results, this new system could help thousands more receive lifesaving transplants—right when they need them.…
B
BioTech Nation ... with Dr. Moira Gunn

1 When Your Immune System Attacks You... Prof. Dr. Niels Riedemann, Co-Founder & CEO, Inflarx 21:52
21:52
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب21:52
This week on BioTech Nation, we explore what happens when your immune system overreacts. Professor Niels Riedemann, CEO of InflaRx, explains how the body’s defense system can sometimes cause more harm than good, leading to serious conditions like rheumatoid arthritis, severe COVID-19, and lung failure. Learn how InflaRx is developing treatments to calm the immune system and why their breakthrough drug is getting attention from U.S. health agencies.…
B
BioTech Nation ... with Dr. Moira Gunn

1 Designing Healthcare for People... Dr. Daniel Kraft, Tech Nation Health Chief Correspondent 7:59
7:59
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب7:59
This week on BioTech Nation, Dr. Daniel Kraft explores how smarter design can make healthcare easier, less stressful, and more effective. From hospitals built for patient comfort to medical apps that adapt to your needs, the way we experience healthcare is evolving. Learn how design thinking and empathy are shaping the future of medicine.…
B
BioTech Nation ... with Dr. Moira Gunn

1 Why One Drug Isn't Always Enough... Rich Daly, President & CEO, Catalyst Pharmaceuticals 19:01
19:01
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب19:01
This week on BioTech Nation, Catalyst Pharmaceuticals CEO Rich Daly discusses the complexities of treating epilepsy and rare diseases. From the challenges of polypharmacy—where patients need multiple drugs to manage a single condition—to the hurdles of diagnosing and treating ultra-rare diseases.
B
BioTech Nation ... with Dr. Moira Gunn

1 A Second Chance for an ALS Drug... Dr. Ari Azhir, Founder & CEO, Neuvivo 17:47
17:47
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب17:47
This week on Biotech Nation, Dr. Ari Azhir, Founder and CEO of Neuvivo, shares the incredible journey of an ALS drug that was once abandoned, but is now making its way toward FDA approval. After two failed phase two trials, the drug was left behind until Dr. Azhir and her team discovered a crucial mistake in the trial data. Now with new insights and groundbreaking survival results, Neuvivo is giving hope to ALS patients and exploring its potential for other neurodegenerative diseases like Huntington’s and Alzheimer’s.…
B
BioTech Nation ... with Dr. Moira Gunn

1 The Mystery of "Dark" Proteins... Dr. Daniel Kraft, Tech Nation Health Chief Correspondent 9:29
9:29
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب9:29
This week on BioTech Nation , Dr. Daniel Kraft explores the discovery of "dark" proteins, thousands of previously unknown proteins in the human body. Scientists believe these hidden proteins could be the key to detecting diseases earlier and developing new treatments.
B
BioTech Nation ... with Dr. Moira Gunn

1 9 Million Samples: A New Era of Medicine... Dr. Lincoln Nadauld, President & CEO, Culmination Bio 18:27
18:27
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب18:27
This week on Biotech Nation, Dr. Lincoln Nadauld shares how Culmination Bio is using 9 million preserved tissue samples and decades of patient data to improve how we understand and treat diseases. From discovering patterns in cancer treatments to exploring breakthroughs in heart and autoimmune diseases, this unique approach is changing medicine.…
B
BioTech Nation ... with Dr. Moira Gunn

1 Mobility: The New Vital Sign….Dr. Daniel Kraft, Tech Nation Health Chief Correspondent 13:50
13:50
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب13:50
This week on Biotech Nation, Dr. Daniel Kraft discusses why mobility is emerging as a key indicator of health, just like heart rate or blood pressure. From wearable tech that tracks your gait to AI-powered exoskeletons and brain-computer interfaces, new innovations are transforming how we measure and maintain movement.…
B
BioTech Nation ... with Dr. Moira Gunn

1 Reprogramming the Future... Dr. Martin Borch Jensen and Dr. Francisco LePort, Gordian Biotechnology 25:51
25:51
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب25:51
This week on Biotech Nation, Dr. Martin Borch Jensen and Dr. Francisco LePort from Gordian Biotechnology share a bold new approach to fighting diseases of aging before they take hold. Instead of testing one drug at a time, their technology allows scientists to test hundreds of potential treatments at once, making drug discovery faster and more precise. This could change how we treat conditions like arthritis, heart failure, and fatty liver disease.…
B
BioTech Nation ... with Dr. Moira Gunn

1 One Drug, Many Diseases??? Dr. David Fajgenbaum, UPenn School of Medicine Professor and President of Every Cure 27:56
27:56
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب27:56
Not just seeking treatment for every disease, but making sure the treatments we have already developed are being used in every possible way. I speak with Dr. David Fajgenbaum (Fay-gen-baum), a Professor of Translational Medicine and Human Genetics at the University of Pennsylvania School of Medicine, and President of Every Cure.…
B
BioTech Nation ... with Dr. Moira Gunn

1 A Daily Pill to Fight Autoimmune Diseases…Ben Zimmer, CEO of Priovant Therapeutics 21:53
21:53
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب21:53
This week on Biotech Nation, Priovant Therapeutics CEO Ben Zimmer shares how their once-a-day pill could transform the treatment of severe autoimmune diseases like dermatomyositis and non-infectious uveitis. With phase 3 trials in progress, Priovant is offering hope to patients with few modern treatment options.…
B
BioTech Nation ... with Dr. Moira Gunn

1 Fighting Inflammation, and Alzheimer's??? Dr. David Bearss, President & CEO Halia Therapeutics 28:57
28:57
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب28:57
In this week's episode of BioTech Nation, Dr. David Bearss, President and CEO of Halia Therapeutics, discusses inflammation and its reduction over a lifetime and in response to various incidents. He unveils the inflammasome, a recently discovered protein complex critical in regulating inflammatory responses and its potential in treating chronic diseases like myelodysplastic syndrome and Alzheimer's. Dr. Bearss shares insights into Halia's groundbreaking approach and his relentless pursuit of medical breakthroughs.…
B
BioTech Nation ... with Dr. Moira Gunn

1 Alcohol-Associated Hepatitis Treatment on the Horizon!!! Dr. Jim Brown, CEO of DURECT 14:52
14:52
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب14:52
Dr. Jim Brown from DURECT talks about their clinical trials for Alcohol-Associated Hepatitis, a condition for which there is no approved treatment.
B
BioTech Nation ... with Dr. Moira Gunn

1 Data for Good!!!... Sir Rory Collins, Oxford Professor and Principal Investigator, UK Biobank 25:34
25:34
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب25:34
Sir Rory Collins is a Professor of Medicine and Epidemiology at the University of Oxford and the Principal Investigator of the UK Biobank. With data from half a million people, it has served 30,000 scientists around the world, giving special support to young researchers and scientists in emergent countries.…
B
BioTech Nation ... with Dr. Moira Gunn

1 Building Technology and Solving Problems!!! Dave Pacitti, President & Head of the Americas, Siemens Healthineers 20:30
20:30
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب20:30
When is a medical technology company more than a medical technology company? We’ll hear all about it when I speak with Dave Pacitti, the President and Head of the Americas at Siemens Healthineers. They’re out to solve problems bigger than the products they are known for.
مرحبًا بك في مشغل أف ام!
يقوم برنامج مشغل أف أم بمسح الويب للحصول على بودكاست عالية الجودة لتستمتع بها الآن. إنه أفضل تطبيق بودكاست ويعمل على أجهزة اندرويد والأيفون والويب. قم بالتسجيل لمزامنة الاشتراكات عبر الأجهزة.